Search

Magdalene K. Sgagias

Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
637
Issued Applications
229
Pending Applications
42
Abandoned Applications
366

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4898947 [patent_doc_number] => 20080118561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Materials and Methods for Minimally-Invasive Administration of a Cell-Containing Flowable Composition' [patent_app_type] => utility [patent_app_number] => 11/792284 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18619 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118561.pdf [firstpage_image] =>[orig_patent_app_number] => 11792284 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792284
Materials and Methods for Minimally-Invasive Administration of a Cell-Containing Flowable Composition Dec 5, 2005 Abandoned
Array ( [id] => 5487099 [patent_doc_number] => 20090276864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'TRANSGENIC ANIMALS WITH REDUCED MAJOR URINARY PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 11/720730 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14217 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20090276864.pdf [firstpage_image] =>[orig_patent_app_number] => 11720730 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/720730
TRANSGENIC ANIMALS WITH REDUCED MAJOR URINARY PROTEIN PRODUCTION Dec 4, 2005 Abandoned
Array ( [id] => 5688950 [patent_doc_number] => 20060287265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Apoptosis-specific eIF-5A and polynucleotides encoding same' [patent_app_type] => utility [patent_app_number] => 11/293391 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 177 [patent_figures_cnt] => 177 [patent_no_of_words] => 54160 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287265.pdf [firstpage_image] =>[orig_patent_app_number] => 11293391 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/293391
Apoptosis-specific eIF-5A and polynucleotides encoding same Dec 4, 2005 Abandoned
Array ( [id] => 5615469 [patent_doc_number] => 20060117399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Animal model for human lymphomas' [patent_app_type] => utility [patent_app_number] => 11/290192 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6632 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20060117399.pdf [firstpage_image] =>[orig_patent_app_number] => 11290192 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/290192
Animal model for human lymphomas Nov 28, 2005 Abandoned
Array ( [id] => 5289962 [patent_doc_number] => 20090022692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'THERAPEUTIC AGENT FOR HEART DISEASE USING MAP KINASE TNNI3K' [patent_app_type] => utility [patent_app_number] => 11/720041 [patent_app_country] => US [patent_app_date] => 2005-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4174 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022692.pdf [firstpage_image] =>[orig_patent_app_number] => 11720041 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/720041
THERAPEUTIC AGENT FOR HEART DISEASE USING MAP KINASE TNNI3K Nov 23, 2005 Abandoned
Array ( [id] => 5517089 [patent_doc_number] => 20090217396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Inflammation models in neurodegenerative and arthritic disorders' [patent_app_type] => utility [patent_app_number] => 11/667392 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 54199 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20090217396.pdf [firstpage_image] =>[orig_patent_app_number] => 11667392 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/667392
Inflammation models in neurodegenerative and arthritic disorders Nov 13, 2005 Abandoned
Array ( [id] => 5215612 [patent_doc_number] => 20070104693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Breast augmentation system' [patent_app_type] => utility [patent_app_number] => 11/268432 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6864 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104693.pdf [firstpage_image] =>[orig_patent_app_number] => 11268432 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/268432
Breast augmentation system Nov 6, 2005 Abandoned
Array ( [id] => 5912420 [patent_doc_number] => 20060127482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Combination of immuno gene therapy & chemotherapy for treatment of cancer & hyperproliferative diseases' [patent_app_type] => utility [patent_app_number] => 11/261931 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10655 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127482.pdf [firstpage_image] =>[orig_patent_app_number] => 11261931 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/261931
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases Oct 27, 2005 Issued
Array ( [id] => 5297572 [patent_doc_number] => 20090012498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Gene therapy for treatment of heart failure' [patent_app_type] => utility [patent_app_number] => 11/665007 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5353 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012498.pdf [firstpage_image] =>[orig_patent_app_number] => 11665007 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/665007
Gene therapy for treatment of heart failure Oct 26, 2005 Abandoned
Array ( [id] => 6649597 [patent_doc_number] => 20100037329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Development of sensitive fret sensors and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/665339 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17549 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20100037329.pdf [firstpage_image] =>[orig_patent_app_number] => 11665339 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/665339
Development of sensitive FRET sensors and methods of using the same Oct 13, 2005 Issued
Array ( [id] => 5721247 [patent_doc_number] => 20060074022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Prevention of primary Sjogren\'s Syndrome by ICA69 deficiency' [patent_app_type] => utility [patent_app_number] => 11/241450 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7859 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074022.pdf [firstpage_image] =>[orig_patent_app_number] => 11241450 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/241450
Prevention of primary Sjogren's Syndrome by ICA69 deficiency Sep 29, 2005 Abandoned
Array ( [id] => 5721267 [patent_doc_number] => 20060074042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Highly hypoxia-specific gene expression system for ischemic gene therapy' [patent_app_type] => utility [patent_app_number] => 11/238664 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3892 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074042.pdf [firstpage_image] =>[orig_patent_app_number] => 11238664 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/238664
Highly hypoxia-specific gene expression system for ischemic gene therapy Sep 27, 2005 Abandoned
Array ( [id] => 5728814 [patent_doc_number] => 20060059575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Method for preparing monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 11/238983 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8216 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20060059575.pdf [firstpage_image] =>[orig_patent_app_number] => 11238983 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/238983
Method for preparing monoclonal antibody Sep 27, 2005 Issued
Array ( [id] => 5631610 [patent_doc_number] => 20060148080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS' [patent_app_type] => utility [patent_app_number] => 11/162715 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19743 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148080.pdf [firstpage_image] =>[orig_patent_app_number] => 11162715 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/162715
METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS Sep 19, 2005 Abandoned
Array ( [id] => 5830892 [patent_doc_number] => 20060064770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Methods for identifying a cell or an embryo carrying a Y chromosome' [patent_app_type] => utility [patent_app_number] => 11/227848 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6214 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20060064770.pdf [firstpage_image] =>[orig_patent_app_number] => 11227848 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/227848
Methods for identifying a cell or an embryo carrying a Y chromosome Sep 14, 2005 Abandoned
Array ( [id] => 5777318 [patent_doc_number] => 20060105958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis' [patent_app_type] => utility [patent_app_number] => 11/224532 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14025 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105958.pdf [firstpage_image] =>[orig_patent_app_number] => 11224532 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224532
Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis Sep 11, 2005 Abandoned
Array ( [id] => 5705271 [patent_doc_number] => 20060194319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Promoter substitution for immunoglobulin therapy' [patent_app_type] => utility [patent_app_number] => 11/219347 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194319.pdf [firstpage_image] =>[orig_patent_app_number] => 11219347 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219347
Promoter substitution for immunoglobulin therapy Sep 1, 2005 Abandoned
Array ( [id] => 4971278 [patent_doc_number] => 20070111280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes' [patent_app_type] => utility [patent_app_number] => 11/218378 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 50473 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111280.pdf [firstpage_image] =>[orig_patent_app_number] => 11218378 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/218378
Compositions and methods for non-targeted activation of endogenous genes Sep 1, 2005 Issued
Array ( [id] => 4761522 [patent_doc_number] => 20080313748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them' [patent_app_type] => utility [patent_app_number] => 11/574671 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17390 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20080313748.pdf [firstpage_image] =>[orig_patent_app_number] => 11574671 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/574671
Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them Sep 1, 2005 Abandoned
Array ( [id] => 5720345 [patent_doc_number] => 20060073119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Methods for treating neurodegenerative disorders' [patent_app_type] => utility [patent_app_number] => 11/218342 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15127 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073119.pdf [firstpage_image] =>[orig_patent_app_number] => 11218342 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/218342
Methods for treating neurodegenerative disorders Aug 31, 2005 Abandoned
Menu